<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Infection and Immunity</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Infection and Immunity</journal-title><trans-title-group xml:lang="ru"><trans-title>Инфекция и иммунитет</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2220-7619</issn><issn publication-format="electronic">2313-7398</issn><publisher><publisher-name xml:lang="en">SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">141</article-id><article-id pub-id-type="doi">10.15789/2220-7619-2013-4-327-334</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">ANALYSIS OF T-HELPER SUBSETS OF PERIPHERAL BLOOD OF PATIENTS WITH CHRONIC HEPATITIS C EXPRESSING CHEMOKINE RECEPTORS CXCR3 AND CCR6 AND ACTIVATION MARKERS CD38 AND HLA-DR</article-title><trans-title-group xml:lang="ru"><trans-title>АНАЛИЗ СУБПОПУЛЯЦИЙ Т-ХЕЛПЕРОВ ПЕРИФЕРИЧЕСКОЙ КРОВИ БОЛЬНЫХ ХРОНИЧЕСКИМ ВИРУСНЫМ ГЕПАТИТОМ С, ЭКСПРЕССИРУЮЩИХ ХЕМОКИНОВЫЕ РЕЦЕПТОРЫ CXCR3 И CCR6 И АКТИВАЦИОННЫЕ МАРКЕРЫ CD38 И HLA-DR</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Elezov</surname><given-names>D. S.</given-names></name><name xml:lang="ru"><surname>Елезов</surname><given-names>Д. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Researcher, Laboratory of Molecular Immunology and Seroepidemiology</p><p>197101, Russian Federation, St. Petersburg, Mira str., 14</p></bio><bio xml:lang="ru"><p>младший научный сотрудник лаборатории иммунологии и сероэпидемиологии</p><p>197101, Россия, Санкт-Петербург, ул. Мира, 14</p></bio><email>elezovds@yahoo.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kudryavtsev</surname><given-names>I. V.</given-names></name><name xml:lang="ru"><surname>Кудрявцев</surname><given-names>И. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD (Biology), Senior Researcher, Department of Immunology, Institute of Experimental Medicine of the North West Branch of the Russian Academy of Medical Sciences; Associated Professor, Department of Fundamental Medicine, Far East Federal University; Associated Professor, Department of Cytology and Histology, St. Petersburg State University</p></bio><bio xml:lang="ru"><p>к.б.н., старший научный сотрудник отдела иммунологии ФГБУ НИИ экспериментальной медицины СЗО РАМН</p><p>доцент кафедры фундаментальной медицины Дальневосточного Федерального Университета</p><p>доцент кафедры цитологии и гистологии Санкт-Петербургского Государственного Университета</p></bio><email>elezovds@yahoo.com</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Arsentieva</surname><given-names>N. A.</given-names></name><name xml:lang="ru"><surname>Арсентьева</surname><given-names>Н. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Researcher, Laboratory of Molecular Immunology and Seroepidemiology</p></bio><bio xml:lang="ru"><p>научный сотрудник лаборатории молекулярной иммунологии и сероэпидемиологии</p></bio><email>elezovds@yahoo.com</email><xref ref-type="aff" rid="aff8"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Semenov</surname><given-names>A. V.</given-names></name><name xml:lang="ru"><surname>Семенов</surname><given-names>А. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD (Biology), Head of Laboratory of Immunology and Epidemiology of HIV infection</p></bio><bio xml:lang="ru"><p>к.б.н., заведующий лабораторией иммунологии и эпидемиологии ВИЧ инфекции</p></bio><email>elezovds@yahoo.com</email><xref ref-type="aff" rid="aff8"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Esaulenko</surname><given-names>E. V.</given-names></name><name xml:lang="ru"><surname>Эсауленко</surname><given-names>Е. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD, MD (Medicine), Professor, Head of the Department of Infectious Disease of Adults and Epidemiology</p></bio><bio xml:lang="ru"><p>д.м.н., профессор, заведующая кафедрой инфекционных болезней взрослых и эпидемиологии</p></bio><email>elezovds@yahoo.com</email><xref ref-type="aff" rid="aff7"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Basina</surname><given-names>V. V.</given-names></name><name xml:lang="ru"><surname>Басина</surname><given-names>В. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Assistant Professor, Department of Infectious Disease of Adults and Epidemiology</p></bio><bio xml:lang="ru"><p>ассистент кафедры инфекционных болезней взрослых и эпидемиологии</p></bio><email>elezovds@yahoo.com</email><xref ref-type="aff" rid="aff7"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Totolian</surname><given-names>Areg A.</given-names></name><name xml:lang="ru"><surname>Тотолян</surname><given-names>Арег А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD, MD (Medicine), Professor, Corresponding Member of the Russian Academy of Medical Sciences, Deputy Director of Research</p></bio><bio xml:lang="ru"><p>член-корреспондент РАМН, д.м.н., профессор, заместитель директора по научной работе</p></bio><email>elezovds@yahoo.com</email><xref ref-type="aff" rid="aff8"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">St. Petersburg Pasteur Institute, St. Petersburg</institution></aff><aff><institution xml:lang="ru">ФБУН НИИ эпидемиологии и микробиологии имени Пастера, Санкт-Петербург</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Institute of Experimental Medicine of the North West Branch of the Russian Academy of Medical Sciences, St. Petersburg</institution></aff><aff><institution xml:lang="ru">ФГБУ НИИ экспериментальной медицины СЗО РАМН, Санкт-Петербург&#13;
&#13;
Дальневосточный федеральный университет, г. Владивосток&#13;
&#13;
Санкт-Петербургский государственный университет, Санкт-Петербург</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Far East Federal University, Vladivostok</institution></aff><aff><institution xml:lang="ru">ФБУН НИИ эпидемиологии и микробиологии имени Пастера, Санкт-Петербург</institution></aff></aff-alternatives><aff-alternatives id="aff4"><aff><institution xml:lang="en">St. Petersburg State University, St. Petersburg</institution></aff><aff><institution xml:lang="ru">ФБУН НИИ эпидемиологии и микробиологии имени Пастера, Санкт-Петербург</institution></aff></aff-alternatives><aff-alternatives id="aff5"><aff><institution xml:lang="en">St. Petersburg Pasteur Institute, St. Petersburg</institution></aff><aff><institution xml:lang="ru">ГБОУ ВПО Санкт-Петербургский государственный педиатрический медицинский университет МЗ РФ, Санкт-Петербург</institution></aff></aff-alternatives><aff-alternatives id="aff6"><aff><institution xml:lang="en">St. Petersburg State Pediatric Medical University, St. Petersburg</institution></aff><aff><institution xml:lang="ru">ФБУН НИИ эпидемиологии и микробиологии имени Пастера, Санкт-Петербург</institution></aff></aff-alternatives><aff id="aff7"><institution>St. Petersburg State Pediatric Medical University, St. Petersburg</institution></aff><aff id="aff8"><institution>St. Petersburg Pasteur Institute, St. Petersburg</institution></aff><pub-date date-type="pub" iso-8601-date="2013-07-08" publication-format="electronic"><day>08</day><month>07</month><year>2013</year></pub-date><volume>3</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>327</fpage><lpage>334</lpage><history><date date-type="received" iso-8601-date="2014-07-08"><day>08</day><month>07</month><year>2014</year></date><date date-type="accepted" iso-8601-date="2014-07-08"><day>08</day><month>07</month><year>2014</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2014, Elezov D.S., Kudryavtsev I.V., Arsentieva N.A., Semenov A.V., Esaulenko E.V., Basina V.V., Totolian A.A.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2014, Елезов Д.С., Кудрявцев И.В., Арсентьева Н.А., Семенов А.В., Эсауленко Е.В., Басина В.В., Тотолян А.А.</copyright-statement><copyright-year>2014</copyright-year><copyright-holder xml:lang="en">Elezov D.S., Kudryavtsev I.V., Arsentieva N.A., Semenov A.V., Esaulenko E.V., Basina V.V., Totolian A.A.</copyright-holder><copyright-holder xml:lang="ru">Елезов Д.С., Кудрявцев И.В., Арсентьева Н.А., Семенов А.В., Эсауленко Е.В., Басина В.В., Тотолян А.А.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://iimmun.ru/iimm/article/view/141">https://iimmun.ru/iimm/article/view/141</self-uri><abstract xml:lang="en"><p><bold>Abstract.</bold> In case of hepatitis C the adequate adaptive immune response depends on T-helper lymphocyte subsets and recruiting specific T cells in the site of infection. The purpose of the study was to assess changes in subpopulations of T-helper cells bearing chemokine receptor CXCR3 and CCR6 and activation markers CD38 and HLA-DR in peripheral blood of patients with chronic hepatitis C (n = 19) and healthy donors (n = 32). The T-helper phenotype was assessed by flow cytometry using a combination of monoclonal antibodies HLA-DR-FITC/CD38-PE/CD3-ECD/CCR6-PE-Cy7/CXCR3-APC/CD4-APC-Cy7. It was demonstrated reduction of CD38+ subset, increase of CXCR3+ and CCR6+ subsets of T-helper cells in particular CD3+CD4+ CXCR3+CCR6+ cells and importance of joint determination of the chemokine receptors CXCR3 and CCR6 and the activation markers CD38 and HLA-DR compared to their separate analysis in chronic hepatitis C.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Резюме.</bold> Адекватный адаптивный иммунный ответ при вирусных инфекциях зависит от Т-хелперных субпопуляций лимфоцитов и привлечения специфических Т-клеток в очаг инфекции. Целью исследования была оценка изменений состава субпопуляций Т-хелперов, несущих на поверхности хемокиновые рецепторы CXCR3 и CCR6 и активационные маркеры CD38 и HLA-DR, в периферической крови больных хроническим вирусным гепатитом С (n = 19) и практически здоровых доноров (n = 24). Содержание субпопуляций определяли методом проточной цитофлюориметрии с использованием комбинации моноклональных антител: HLA-DR-FITC/CD38-PE/CD3-ECD/CCR6-PE-Cy7/CXCR3-APC/CD4-APC-Cy7. Установлено сниженное количество CD38+ Т-хелперов и повышенное CXCR3 и CCR6 экспрессирующих Т-хелперов, в частности субпопуляции CD3+CD4+CXCR3+CCR6+ клеток. Показана значимость сочетанного определения комбинаций хемокиновых рецепторов CXCR3 и CCR6 и активационных маркеров CD38 и HLA-DR по сравнению с их раздельным анализом при хроническом гепатите С.</p></trans-abstract><kwd-group xml:lang="en"><kwd>hepatitis C</kwd><kwd>T-helpers</kwd><kwd>chemokine receptors</kwd><kwd>activation markers</kwd><kwd>CXCR3</kwd><kwd>CCR6</kwd><kwd>CD38</kwd><kwd>HLA-DR</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>гепатит С</kwd><kwd>Т-хелперы</kwd><kwd>хемокиновые рецепторы</kwd><kwd>активационные маркеры</kwd><kwd>CXCR3</kwd><kwd>CCR6</kwd><kwd>CD38</kwd><kwd>HLA-DR</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>1.	Арсентьева Н.А., Семенов А.В., Тотолян А.А. Роль полиморфизма генов цитокинов при вирусном гепатите С // Инфекция и иммунитет. — 2012. — Т. 2, № 4. — С. 687–698. Arsent`eva N.A., Semenov A.V., Totolian A.A. Rol` polimorfizma genov tsitokinov pri virusnom gepatite S [The role of cytokine gene polymorphism in hepatitis C virus infection]. Infektsiya i immunitet — Infection and Immunity, 2012, vol. 2, no. 4, pp. 687–698.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>2.	Вирусные гепатиты в Российской Федерации. Аналитический обзор. 8 выпуск / Под ред. В.И. Покровского, А.Б. Жебруна. — СПб.: ФБУН НИИЭМ имени Пастера, 2011. — 116 с. Virusnye gepatity v Rossiyskoy Federatsii. Analiticheskiy obzor. 8 vypusk (Pod red. V.I. Pokrovskogo, A.B. Zhebruna) [Viral hepatitis in Russian Federation. Analytical review. Issue 8 (Ed. Pokrovskiy V.I., Zhebrun A.B.)]. St. Petersburg Pasteur Institute, 2011. 116 p.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>3.	Жданов К.В., Гусев Д.А., Чирский B.C., Сысоев К.А., Якубовская Л.А., Шахманов Д.М., Тотолян А.А. Хроническая HCV-инфекция и экспрессия мРНК СС-хемокинов и их рецепторов // Журнал микробиологии, эпидемиологии и иммунобиологии. — 2008. — № 4. — С. 73–78. Zhdanov K.V., Gusev D.A., Chirskiy B.C., Sysoev K.A., Yakubovskaya L.A., Shakhmanov D.M., Totolian A.A. Hronicheskaya HCV-infektsiya i ekspressiya mRNK SS-khemokinov i ikh retseptorov [Chronic HCV infection and mRNA expression of CC-chemokines and their receptors]. Zhurnal mikrobiologii, epidemiologii i immunobiologii — Journal of Microbiology, Epidemiology and Immunobiology, 2008, vol. 4, pp. 73–78.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>4.	Сысоев К.А., Чухловин А.Б., Тотолян А.А. Диагностическая роль определения хемокинов и их рецепторов при хроническом гепатите С // Клин. лабораторная диагностика. — 2013. — № 2. — С. 23–29. Sysoev K.A., Chukhlovin A.B., Totolian A.A. Diagnosticheskaya rol` opredeleniya khemokinov i ikh retseptorov pri khronicheskom gepatite S [The diagnostic role of chemokines and their receptors in chronic hepatitis C]. Klinicheskaya laboratornaya diagnostika — Clinical Laboratory Diagnostics, 2013, vol. 2, pp. 23–29.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>5.	Сысоев К.А., Чухловин А.Б., Шахманов Д.М., Жданов К.В., Тотолян А.А. Профиль цитокинов и хемокинов в плазме крови пациентов с хроническим гепатитом С // Инфекция и иммунитет. — 2013. — Т. 3, № 1. — С. 49–58. Sysoev K.A., Chukhlovin A.B., Shakhmanov D.M., Zhdanov K.V., Totolian A.A. Profil` tsitokinov i khemokinov v plazme krovi patsientov s khronicheskim gepatitom S [Cytokines and chemokines in the blood plasma of patients with chronic hepatitis C]. Infektsiya i immunitet — Infection and Immunity, 2013, vol. 3, no. 1, pp. 49–58.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>6.	Хайдуков С.В., Байдун Л.А., Зурочка А.В., Тотолян А.А. Стандартизованная технология «Исследование субпопуляционного состава лимфоцитов периферической крови с применением проточных цитофлюориметров-анализаторов» (Проект) // Медицинская иммунология. — 2012. — Т. 14, № 3. — С. 255–268. Khaidukov S.V., Baydun L.A., Zurochka A.V., Totolian A.A. Standartizovannaya tekhnologiya “Issledovanie subpopulyatsionnogo sostava limfotsitov perifericheskoy krovi s primeneniem protochnykh tsitoflyuorimetrov-analizatorov” (Proekt) [Standard technology “Flow cytometric immunophenotyping of peripheral blood lymphocytes” (Draft version)]. Meditsinskaya immunologiya — Medical Immunology, 2012, vol. 12, no. 3, pp. 255–268.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>7.	Annunziato F., Cosmi L., Liotta F., Maggi E., Romagnani S. The phenotype of human Th17 cells and their precursors, the cytokines that mediate their differentiation and the role of Th17 cells in inflammation. Int. Immunol., 2008, vol. 20, pp. 1361–1368.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>8.	Bromley S., Mempel T., Luster A. Orchestrating the orchestrators: chemokines in control of T cell traffic. Nat. Immunol., 2008, vol. 9, pp. 970–980.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>9.	Butera D., Marukian S., Iwamaye A., Hembrador E., Chambers T., Di Bisceqlie A., Charles E., Tatal A., Jacobson I., Rice C., Dustin L. Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C. Blood, 2005, vol. 106, pp. 1175–1182.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>10.	Casrouge A., Decalf J., Ahloulay M., Lababidi C., Mansour G., Vallet-Pichard A., Mallet V., Mottez E., Mapes J., Fontanet A., Pol S., Albert M. Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV. J. Clin. Invest., 2011, vol. 121, pp. 308–317.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>11.	Crome S., Clive B., Wang A, Kang C, Chow V., Yu J., Lai A., Ghahary A., Broady R., Levings M. Inflammation effects of ex vivo human Th17 cells are suppressed by regulatory T cells. J. Immunol., 2010, vol. 185, pp. 3199–3208.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>12.	Diago M., Castellano G., Garcia-Samaniego J., Perez C., Fernandez I., Romero M., Iacono O., Garcia-Monson C. Association of pretreatment serum interferon gamma inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C. Gut, 2006, vol. 55, pp. 374–379.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>13.	Gonzales V., Falconer K., Blom K., Reichard O., Morn B., Laursen A., Weis N., Alaeus A., Sandberq J. High levels of chronic activation in the T-cell compartments of patients coinfected with hepatitis C virus type 1 and on highly active antiretroviral therapy are reverted by alpha interferon and ribavirin treatment. J. Virol., 2009, vol. 83, pp. 11407–11411.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>14.	Groom J., Luster A. CXCR3 in T cell function. Exp. Cell Res., 2011, vol. 317, pp. 620–631.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>15.	Lauer G., Walker B. Hepatitis C virus infection. N. Engl. J. Med., 2001, vol. 345, pp. 41–52.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>16.	Maecker H., McCoy P., Nussenblatt R. Standardizing immunophenotyping for the human immunology project. Nat. Rev. Immunol., 2012, vol. 12, pp. 191–200.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>17.	Oo Y., Banz V., Kavanagh D., Liaskou E., Withers D., Humphreys E., Reynolds G., Lee-Turner L., Kalia N., Hubscher S., Klenerman P., Eksteen B., Adams D. CXCR3-dependent recruitment and CCR6-mediated positioning of Th-17 cells in the inflamed liver. J. Hepatol., 2012, vol. 57, pp. 1044–1051.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>18.	Oo Y., Shetty S., Adams D. The role of chemokines in the recruitment of lymphocytes to the liver. Dig. Dis., 2010, vol. 28, pp. 31–44.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>19.	Zeremski M., Petrovic L., Talal A. The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection. J. Viral Hepat., 2007, vol. 14, pp. 675–687.</mixed-citation></ref></ref-list></back></article>
